In the recent past, gene profiling in tumor tissues suggests that breast cancers are divided into subtypes dependent on the presence or absence of oestrogen receptor, progesterone, and human epidermal growth factor receptor 2 (HER 2).These subtypes do have distinctive clinical outcomes and perhaps risk factors from past studies. This evidence concerns the gene ERBB2 and breast cancer.